Our Pipeline

Sardocor has 3 ongoing FDA-approved clinical trials and 7 additional pre-clinical gene therapy (4) and small molecule (3) programs in the pipeline. With the mini-Heart and mini-Life Platforms, the total number of novel pre-clinical candidates is continuing to grow as existing ones advance to the next clinical stages.